MedPath

HORIZON THERAPEUTICS IRELAND DAC

🇪🇸Spain
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Study to Evaluate HZN-457 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2022-10-04
Last Posted Date
2023-09-07
Lead Sponsor
Horizon Therapeutics Ireland DAC
Target Recruit Count
36
Registration Number
NCT05565768
Locations
🇳🇿

New Zealand Clinical Research, Christchurch, New Zealand

© Copyright 2025. All Rights Reserved by MedPath